V
Dexcom doubles down on nondiabetic CGM use.
First off, it announced today that it plans to acquire Nutrisense — a CGM startup that targets nondiabetics. Stelo, its over-the-counter CGM, is also getting an FDA-cleared redesign that includes “pattern recognition, proactive AI coaching, and personalized weekly and daily summaries.” Hopefully, these moves help ease the data fatigue I experienced in my yearlong experiment with CGMs as a nondiabetic.
Follow topics and authors from this story to see more like this in your personalized homepage feed and to receive email updates.
Loading comments
Getting the conversation ready...
Most Popular
Most Popular
- OpenAI pauses training of its ‘most capable models’
- Apple hit with $5.7 billion in damages over haptic patents
- Control Resonant is a great game — it’s even better when you read everything
- Leaks reveal a new Apple HomePod mini, iPad mini, and Apple TV 4K
- Can Apple Home’s AI camera features outsmart Amazon’s and Google’s? I put them to the test












